glaxosmithkline News

Supreme Court Rejects Teva Challenge to $235 Million GSK Award in Patent Dispute

The U.S. Supreme Court on Monday declined to hear Teva Pharmaceuticals USA Inc’s challenge to a $235 million award to GlaxoSmithKline LLC in a patent dispute over generic drugs involving a heart medication. The justices turned away Israel-based Teva’s appeal …

Britain’s Haleon Rejects Potential Zantac Liabilities in U.S.

Haleon believes it is not liable for any claims that may arise from U.S. litigation over the heartburn drug Zantac, the London-listed company’s CEO Brian McNamara told Reuters on Tuesday. More than 2,000 legal cases related to Zantac have been …

Who’s On the Hook If COVID-19 Vaccines Go Wrong?: Viewpoint

The COVID-19 vaccines are here and distribution has begun. But what if something goes wrong? Whether it’s a loss of income, hefty medical bills or other serious adverse effects from getting a shot, someone has to pick up the tab, …

Drugmakers Plan to Raise Prices in New Year: Reuters, 3 Axis Advisors

Drugmakers including Pfizer Inc., Sanofi SA, and GlaxoSmithKline Plc plan to raise U.S. prices on more than 300 drugs in the United States on Jan. 1, according to drugmakers and data analyzed by healthcare research firm 3 Axis Advisors. The …

Appeals Court Reinstates Glaxo $235.5 Million Verdict Against Teva

A federal appeals court on Friday reinstated a 2017 jury verdict ordering Teva Pharmaceutical Industries Ltd. to pay GlaxoSmithKline Plc $235.5 million for selling a generic version of Glaxo’s heart drug Coreg. In a 2-1 decision, the U.S. Federal Circuit …

Limited Liability Protection for Drugmakers Hampers EU Coronavirus Vaccine Deals

The European Union is offering only partial protection to vaccine makers against legal risks from side-effects of their potential COVID-19 shots, European officials said, in a move that is hampering deals and contrasts with U.S. policy. With vaccines being developed …

GlaxoSmithKline Shuts Down N.C. Factory Due to Legionnaires’ Bacteria

Drugmaker GlaxoSmithKline closed its North Carolina factory on Tuesday after testing at a cooling tower found bacteria that causes deadly Legionnaire’s disease, a company spokeswoman said. The Legionella bacteria was discovered during routine inspections at the site in Zebulon, N.C., …

Pfizer Refutes Claims of Zoloft Link to Birth Defects

Pfizer Inc. researchers concluded last year that pregnant women taking Zoloft risked having babies with heart defects, according to evidence made public by a lawyer at the first trial of more than 1,000 lawsuits over the drug. The May 2014 …

Supreme Court Will Not Hear Drugmaker’s Appeal of Insurer’s Medicare Reimbursement Claim

The U.S. Supreme Court on Monday declined to consider whether private insurers can sue giant drugmaker GlaxoSmithKline Plc over health costs incurred by its Avandia diabetes drug. Humana Inc.’s Humana Medical Plans had sued Glaxo for healthcare expenses Medicare patients …

Drug Maker Sues Louisiana AG in Avandia Drug Case

Drug maker GlaxoSmithKline has filed suit against Louisiana Attorney General Buddy Caldwell, alleging that private attorneys hired by Caldwell to prosecute the state’s lawsuit against the company have a “personal financial interest” in the suit’s outcome. The Advocate reports GlaxoSmithKline …